All questions are shown as received by the Trust.
Q1a – How many patients were treated with the following drugs for the following diseases from the start of Jul 2024 to the end of Sept 2024?
Q1b – How many patients were treated with Ustekinumab and its biosimilars from the start of Jul 2024 to the end of Sept 2024?
